CTXR vs ZION · rev $7.1M vs P/E 11, rev $354.0M
Citius Pharmaceuticals Inc (CTXR) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
CTXR currently screens at market cap $13.4M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the CTXR and ZION stock pages for the full models.
Not investment advice.